5
Participants
Start Date
August 31, 2007
Primary Completion Date
March 31, 2010
Study Completion Date
March 31, 2010
local injection of bevacizumab
Upon enrollment into the study: - initial injection of bevacizumab, a 1 week post-injection visit,and monthly visits thereafter for a total of 6 months. At the 1-month and 3-month visit post-injection visit, an additional bevacizumab injection will be offered if pterygium regression has not occurred. All injections of bevacizumab will consist of injecting 0.1mL of a 2.5mg/0.1mL concentration of bevacizumab into the head of the pterygium.
Callahan Eye Foundation Hospital, Birmingham
University of Alabama at Birmingham
OTHER